Diffuse large B cell lymphoma: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Infobox_Disease
| Name          = {{PAGENAME}}
| Image          =
| Caption        =
| DiseasesDB    =
| ICD10          =
| ICD9          =
| ICDO          = 9680/3
| OMIM          =
| MedlinePlus    =
| MeshID        = }}
{{Diffuse large B cell lymphoma}}
{{Diffuse large B cell lymphoma}}


Line 44: Line 22:
==[[Diffuse large B cell lymphoma risk factors|Risk Factors]]==
==[[Diffuse large B cell lymphoma risk factors|Risk Factors]]==


==[[Diffuse large B cell lymphoma screening|Screening]]==
==[[Diffuse large B cell lymphoma natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 
==[[Diffuse large B cell lymphoma natural history|Natural History, Complications and Prognosis]]==


== Diagnosis ==  
== Diagnosis ==  
Line 54: Line 30:
==Treatment==
==Treatment==


[[Diffuse large B cell lymphoma medical therapy| Medical Therapy]] | [[Diffuse large B cell lymphoma surgery| Surgery]] | [[Diffuse large B cell lymphoma primary prevention| Primary Prevention]] | [[Diffuse large B cell lymphoma secondary prevention|Secondary Prevention]] | [[Diffuse large B cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Diffuse large B cell lymphoma future or investigational therapies|Future or Investigational Therapies]]
[[Diffuse large B cell lymphoma medical therapy| Medical Therapy]] | [[Diffuse large B cell lymphoma surgery| Surgery]] | [[Diffuse large B cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Diffuse large B cell lymphoma future or investigational therapies|Future or Investigational Therapies]]


==Case Studies==
==Case Studies==

Revision as of 04:58, 21 August 2015

Diffuse large B cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diffuse large B cell lymphoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diffuse large B cell lymphoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diffuse large B cell lymphoma

CDC on Diffuse large B cell lymphoma

Diffuse large B cell lymphoma in the news

Blogs on Diffuse large B cell lymphoma

Directions to Hospitals Treating Diffuse large B cell lymphoma

Risk calculators and risk factors for Diffuse large B cell lymphoma

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diffuse large B cell lymphomafrom other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Biopsy | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Template:Tumors


Template:WikiDoc Sources